Particle Replication in Nonwetting Templates Nanoparticles with Tumor Selective Alkyl Silyl Ether Docetaxel Prodrug Reduces Toxicity
Nano Letters2014Vol. 14(3), pp. 1472–1476
Citations Over TimeTop 10% of 2014 papers
Kevin S. Chu, Mathew C. Finniss, Allison N. Schorzman, Jennifer L. Kuijer, J. Christopher Luft, Charles J. Bowerman, Mary E. Napier, Zishan A. Haroon, William C. Zamboni, Joseph M. DeSimone
Abstract
Delivery systems designed to have triggered release after passively targeting the tumor may improve small molecule chemotherapeutic delivery. Particle replication in nonwetting templates was used to prepare nanoparticles to passively target solid tumors in an A549 subcutaneous xenograft model. An acid labile prodrug was delivered to minimize systemic free docetaxel concentrations and improve tolerability without compromising efficacy.
Related Papers
- Docetaxel (Taxotere): preclinical and general clinical information.(1999)
- → The plinabulin/docetaxel combination to mitigate the known safety concerns of docetaxel.(2016)3 cited
- → Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer(2002)18 cited
- Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner.(2001)
- TS-1 による術後補助療法中に発症しWeekly Docetaxel 療法により著効をみた胃癌腹膜播種の1 例(2005)